Executives On The Move: New Chief Financial Officer Joins Genfit, BioVie Gets New CEO
Seneca shakes up leadership team with new CEO and chief financial officer, along with a board reshuffle.
You may also be interested in...
Magnus Christensen takes over as Medivir's interim CEO, while Yilmaz Mahshid joins the board. Meanwhile, bluebird bio appoints a new chief commercial officer for severe genetic disease and ARCA biopharma appoints a new CFO and VP of clinical development.
France's Valneva raises new funds to progress its inactivated vaccine, while Scotland launches a new study into 'long COVID', Takeda reports positive interim results from a Japanese trial with Moderna's mRNA vaccine, a setback for GC's plasma therapy, and Celltrion begins exporting a therapeutic antibody.
Executive reshuffle at Karyopharm Therapeutics, plus new chief financial officers at Redx Pharma and Vaccibody.